TRANS AMERICAN AQUACULTURE, INC. financials

GRPS CIK 0001990446

Source: EDGAR filings · Built 2026-06-19T00:59:39Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2024FY 2023FY 2023FY 2023
Free Cash Flow -1.12M -505.90K -1.27M
Working Capital -3.35M -3.48M -2.49M
Net Debt 616.53K 4.85M 4.91M
Gross Margin 3.02% -551.34% -485.97% -207.93%
Net Margin -846.96% -1865.63% -1883.26% -443.46%
Return on Equity (ROE) 87.18% 395.39% -253.33% -180.43%
Return on Assets (ROA) -296.29% -24.73% -12.03%
Current Ratio 0.07× 0.07× 0.08×
Debt-to-Equity -0.19× -10.14× 13.47×
Effective Tax Rate 0.00% 1.40% -3.01% 0.00%
Cash Conversion Ratio 1.07× 0.58× 0.55× 0.90×
Accruals Ratio 0.20× -0.10× -0.05×
CapEx Coverage -73.22× -304.04×
Free Cash Flow Per Share $-0.00 $-0.00

Income Statement

Concept FY 2024FY 2023FY 2023FY 2023
Revenues 331.64K 101.57K 49.00K 316.11K
Cost of Revenue 321.62K 661.59K 287.13K 973.42K
Gross Profit 10.03K -560.02K -238.13K -657.31K
Income Tax Expense (Benefit) 0 -26.94K 26.94K 0
Net Income (Loss) Attributable to Parent -2.81M -1.89M -922.82K -1.40M
Earnings Per Share, Basic $-0.00 $-0.00 $-0.00 $0.00
Weighted Average Number of Shares Outstanding, Basic 1.81B 1.45B 1.29B 0
Earnings Per Share, Diluted $-0.00 $-0.00 $-0.00 $0.00

Balance Sheet

Concept FY 2024FY 2023FY 2023FY 2023
Cash and Cash Equivalents, at Carrying Value 0 6.60K 0
Assets, Current 257.31K 253.99K 207.60K
Assets 948.01K 7.66M 7.67M
Long-term Debt 54.47K 4.33M 4.58M
Liabilities, Current 3.61M 3.73M 2.70M
Stockholders' Equity Attributable to Parent -3.22M -479.28K 364.27K 776.96K
Common Stock, Shares, Outstanding 1.81B 1.65B 1.65B

Cash Flow Statement

Concept FY 2024FY 2023FY 2023FY 2023
Net Cash Provided by (Used in) Operating Activities -3.00M -1.11M -505.90K -1.26M
Net Cash Provided by (Used in) Investing Activities 6.72M -15.13K 0 -4.16K
Payments of Dividends 0 0 0 0
Net Cash Provided by (Used in) Financing Activities -3.73M 1.13M 505.90K 1.27M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GRPS CIK 0001990446), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

KNTK

KINETIK HOLDINGS INC.

SPEG

SILVER PEGASUS ACQUISITION CORP.

CANF

Can-Fite BioPharma Ltd.